These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9647140)

  • 1. Endothelial-related coagulation in pediatric surgery.
    Boldt J
    Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S56-9; discussion S74-6. PubMed ID: 9647140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of aprotinin on the thrombomodulin/protein C system in pediatric cardiac operations.
    Boldt J; Zickmann B; Schindler E; Welters A; Dapper F; Hempelmann G
    J Thorac Cardiovasc Surg; 1994 May; 107(5):1215-21. PubMed ID: 7513776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RETRACTED: Does aprotinin influence endothelial-associated coagulation in cardiac surgery?
    Boldt J; Schindler E; Knothe C; Hammermann H; Stertmann WA; Hempelmann G
    J Cardiothorac Vasc Anesth; 1994 Oct; 8(5):527-531. PubMed ID: 7528560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the anticoagulation regimen on endothelial-related coagulation in cardiac surgery patients.
    Boldt J; Schindler E; Welters I; Wittstock M; Stertmann WA; Hempelmann G
    Anaesthesia; 1995 Nov; 50(11):954-60. PubMed ID: 8678251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage.
    Mössinger H; Dietrich W
    Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S45-50; discussion S50-1, S74-6. PubMed ID: 9647138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Duraflo II heparin-coated cardiopulmonary bypass circuits on the coagulation system, endothelial damage, and cytokine release in patients with cardiac operation employing aprotinin and steroids.
    Inui K; Shimazaki Y; Watanabe T; Takahashi T; Minowa T; Takeda H; Yanagawa N; Sotoda Y
    Artif Organs; 1999 Dec; 23(12):1107-12. PubMed ID: 10619929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypass.
    Khan MM; Gikakis N; Miyamoto S; Rao AK; Cooper SL; Edmunds LH; Colman RW
    Ann Thorac Surg; 1999 Aug; 68(2):473-8. PubMed ID: 10475415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generation.
    Tanaka KA; Szlam F; Levy JH
    Br J Haematol; 2006 Jul; 134(1):77-82. PubMed ID: 16803571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pump-prime aprotinin dose in cardiac surgery: appraisal of its effects on the hemostatic system.
    Rossi M; Storti S; Martinelli L; Varano C; Marra R; Zamparelli R; Possati G; Schiavello R
    J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):835-9. PubMed ID: 9412880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease.
    Welters I; Menges T; Ballesteros M; Knothe C; Ruwoldt R; Görlach G; Hempelmann G
    Thromb Res; 1998 Oct; 92(1):1-9. PubMed ID: 9783668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombomodulin in pediatric cardiac surgery.
    Boldt J; Knothe C; Schindler E; Welters A; Dapper FF; Hempelmann G
    Ann Thorac Surg; 1994 Jun; 57(6):1584-9. PubMed ID: 8010806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation.
    Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Kawashima Y
    Circulation; 1996 Nov; 94(9 Suppl):II177-81. PubMed ID: 8901742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations.
    Miller BE; Tosone SR; Tam VK; Kanter KR; Guzzetta NA; Bailey JM; Levy JH
    Ann Thorac Surg; 1998 Aug; 66(2):535-40; discussion 541. PubMed ID: 9725399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
    Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin in cardiac surgery.
    Sodha NR; Boodhwani M; Bianchi C; Ramlawi B; Sellke FW
    Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):151-60. PubMed ID: 16509811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin: antifibrinolytic and anti-inflammatory mechanisms of action in cardiac surgery with cardiopulmonary bypass.
    Donahue MA; Price PM
    Dynamics; 2002; 13(3):16-23. PubMed ID: 12640841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trasylol Pediatric Investigational Meeting. Introduction.
    Greeley WJ
    Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S29-30. PubMed ID: 9647134
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid.
    Menichetti A; Tritapepe L; Ruvolo G; Speziale G; Cogliati A; Di Giovanni C; Pacilli M; Criniti A
    J Cardiovasc Surg (Torino); 1996 Aug; 37(4):401-7. PubMed ID: 8698787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aprotinin and hemostasis monitoring concerns during cardiac surgery.
    Swartz MF; Fink GW; Searles B
    J Extra Corpor Technol; 2004 Dec; 36(4):375-83. PubMed ID: 15679283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of novel synthetic serine protease inhibitors on postoperative blood loss, coagulation parameters, and vascular relaxation after cardiac surgery.
    Szabó G; Veres G; Radovits T; Haider H; Krieger N; Bährle S; Miesel-Gröschel C; Niklisch S; Karck M; van de Locht A
    J Thorac Cardiovasc Surg; 2010 Jan; 139(1):181-8; discussion 188. PubMed ID: 20106364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.